Orchid Pharma Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,011.15 -22.85 (-2.21%)Updated : 18 Jun 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	812.23	838.98	741.74	597.70
Other Net	35.17	4.07	7.78	-4.98
Diluted Weighted Average Shares	5.07	5.07	4.84	4.08
Depreciation/ Amortization	35.45	34.55	33.24	54.79
Operating Income	-0.90	82.65	77.63	68.20
Net Income	20.55	99.66	92.17	46.32
Income Availableto Com Excl Extra Ord	20.55	99.66	92.17	53.09
Other Operating Expenses Total	152.85	65.05	55.16	-
Net Income Before Taxes	21.02	95.56	91.95	55.25
Net Income After Taxes	21.21	95.76	95.06	55.25
Income Availableto Com Incl Extra Ord	20.55	99.66	92.17	46.32
Costof Revenue Total	525.88	628.59	561.31	458.44
Gross Profit	285.45	293.04	258.06	207.46
Interest Inc( Exp) Net- Non- Op Total	-13.26	9.17	6.73	-8.75
Unusual Expense( Income)	6.57	0.00	0.00	-39.21
Diluted Net Income	20.55	99.66	92.17	46.32
Provisionfor Income Taxes	-0.19	-0.19	-3.12	0.00
Equity In Affiliates	-0.66	3.90	-2.90	-2.15
period Type	-	-	-	-
Net Income Before Extra Items	20.55	99.66	92.17	53.09
Total Revenue	811.33	921.63	819.37	665.90
period Length	12.00	12.00	12.00	12.00
Revenue	811.33	921.63	819.37	665.90
Selling/ General/ Admin Expenses Total	91.47	102.43	84.94	117.32
Diluted Normalized EPS	4.89	19.69	19.08	3.21
Diluted EPS Excluding Extra Ord Items	4.05	19.65	19.06	13.01
Gain( Loss)on Saleof Assets	-	-0.32	-0.19	0.77
Total Extraordinary Items	-	0.00	0.00	-6.78
Research Development	-	8.37	7.09	6.36

*All figures in crores except per share values

Trending Stocks

2,991.00+94.00(3.24%)

261.55+8.00(3.16%)

1,469.45+23.35(1.61%)

390.15-3.45 (-0.88%)

352.80-2.65 (-0.75%)

Related News